Heritage Group has announced the closing of its oversubscribed third fund with more than $300 million.
Heritage Group, based in Nashville, Tenn., makes control and minority equity investments exclusively in the healthcare industry. Founded in 1986, the firm has flexibility on investment size, including interest in pre-EBITDA businesses, as it pursues provider services companies…
The next in our series of posts sharing key takeaways from panels at the Healthcare & Life Sciences Private Equity and Lending Conference is authored by myself and my colleagues Tim Fry and Amanda Roenius.
* * *
Physician Perspectives on Finding the Right Investment Partner — 6 Key Points
by Amber Walsh, Tim Fry,…
The next in our series of posts sharing key takeaways from panels at the Healthcare & Life Sciences Private Equity and Lending Conference is authored by our colleagues Alyssa Campbell and Amanda Roenius.
* * *
Structuring PPM and DPM Transactions for Maximum Success: Tackling Front-End Issues
By Alyssa Campbell and Amanda Roenius
In order…
The Blackstone Group has announced the closing of its acquisition of Clarus. The business will now operate as Blackstone Life Sciences.
Blackstone indicated that its new private investment platform will invest across the lifecycle of companies and products within life sciences sectors.
Historical funds will retain the Clarus name.
Blackstone had previously announced its acquisition…
It’s deal time! The 2016 JP Morgan Healthcare Conference has set the tone for another successful year for healthcare investing. A company’s financial health is a key factor in the underwriting process for any type of loan and, in the healthcare space, savvy investors also conduct through healthcare regulatory diligence. Sophisticated investors, however, go beyond…
